Venclyxto receives EC approval in combination with a hypomethylating agent for patients with ...

Retrieved on: 2021-05-28 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

Venclyxto receives EC approval in combination with a hypomethylating agent for patients with .... View article details on hiswai:

Excerpt

Venclyxto is being developed by AbbVie and Roche. It is jointly commercialized by AbbVie and Genentech, a member of the Roche Group, in the U.S. ...

Article found on: cancerletter.com